Answers are grounded in this paper and cite their sources.
Randomized trial demonstrates resonant therapy induces apoptosis in cancer cells, suggesting a novel treatment method.
This work (Publication №20 of Resonance Group) presents a theory and practical protocol for resonant cancer therapy based on the concept of malignant transformation as a local topological eversion (phase inversion) — the transition of a cell from the resonant Series A to the dissonant Series B. The dominant frequency of a cancer cell is given by f_cancer = 57 × √7 × T Hz, where 57 Hz is the base frequency of the standing layer, √7 ≈ 2.64575 is the dissonant transition coefficient, and T is the triangulation number characteristic of the tumor type. Healthy cells synchronize with 57 Hz and its harmonics. Cancer arises from a local eversion (256 ≡ 0, 180° phase shift) that drives the cell into an uncontrolled dissonant mode. Exposure of the tumor to frequency f_cancer in antiphase (180° shift) resonantly damps the pathological pulsation and induces apoptosis. The protocol includes frequency diagnostics (biopsy, spectroscopy, T‑number calculation), exposure (30–60 min daily, 10–20 sessions), and efficacy control (PET/CT, biopsy, circulating tumor cells). The method is non‑invasive, non‑toxic, induces no resistance, and can be combined with existing therapies. Calculated frequencies for various cancer types are provided (melanoma: 151.14 Hz, breast cancer: 604.56 Hz, lung cancer: 1057.98 Hz, glioblastoma: 1967.14 Hz, etc.). A comparison with chemotherapy, radiotherapy, and immunotherapy is included. Clinical trials are invited.
No takes yet. Share an insight, caveat, or question.
Mark Markov (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: